Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wehling

Showing results (41-50 of 164) with videos related to

Pageof 17
Sort By:
Trends in Endocrinology and Metabolism: TEM|November 17, 2022
Many or too many progesterone membrane receptors? Clinical implicationsAlexandra Wendler, Martin Wehling
European Journal of Clinical Pharmacology|June 6, 2023
Translatability scoring in prospective and retrospective COVID drug development casesAlexandra Wendler, Martin Wehling
Innere Medizin (Heidelberg, Germany)|December 8, 2023
[The FORTA (Fit fOR The Aged) List]Farhad Pazan, Martin Wehling
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 3, 2003
Clinical research in Germany--quo vadis? New activities of the German Diabetes Association and the German Society of EndocrinologyMartin Wehling, Helmut Schatz
European Geriatric Medicine|November 5, 2021
Deprescribing or represcribing: not just a semantic dilemmaMartin Wehling, Mirko Petrovic
Journal of Translational Medicine|March 9, 2012
Translatability scoring in drug development: eight case studiesAlexandra Wendler, Martin Wehling
Journal of Translational Medicine|November 5, 2017
Translatability score revisited: differentiation for distinct disease areasAlexandra Wendler, Martin Wehling
Seminars in Thrombosis and Hemostasis|April 9, 2008
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIaJob Harenberg, Martin Wehling
Hypertension (Dallas, Tex. : 1979)|March 23, 2011
Is GPR30 the membrane aldosterone receptor postulated 20 years ago?Alexandra Wendler, Martin Wehling
European Geriatric Medicine|March 11, 2021
Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequencesFarhad Pazan, Martin Wehling
Pageof 17

Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
Trends in Endocrinology and Metabolism: TEM|November 17, 2022
Many or too many progesterone membrane receptors? Clinical implicationsAlexandra Wendler, Martin Wehling
European Journal of Clinical Pharmacology|June 6, 2023
Translatability scoring in prospective and retrospective COVID drug development casesAlexandra Wendler, Martin Wehling
Innere Medizin (Heidelberg, Germany)|December 8, 2023
[The FORTA (Fit fOR The Aged) List]Farhad Pazan, Martin Wehling
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 3, 2003
Clinical research in Germany--quo vadis? New activities of the German Diabetes Association and the German Society of EndocrinologyMartin Wehling, Helmut Schatz
European Geriatric Medicine|November 5, 2021
Deprescribing or represcribing: not just a semantic dilemmaMartin Wehling, Mirko Petrovic
Journal of Translational Medicine|March 9, 2012
Translatability scoring in drug development: eight case studiesAlexandra Wendler, Martin Wehling
Journal of Translational Medicine|November 5, 2017
Translatability score revisited: differentiation for distinct disease areasAlexandra Wendler, Martin Wehling
Seminars in Thrombosis and Hemostasis|April 9, 2008
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIaJob Harenberg, Martin Wehling
Hypertension (Dallas, Tex. : 1979)|March 23, 2011
Is GPR30 the membrane aldosterone receptor postulated 20 years ago?Alexandra Wendler, Martin Wehling
European Geriatric Medicine|March 11, 2021
Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequencesFarhad Pazan, Martin Wehling
Pageof 17